We next evaluated CD44 expression by flow cytometry in both CD109 KO and control A431 cells, as CD44 is a cancer stem cell (CSC) marker that is involved in the regulation of CSC survival, self-renewal, and metastatic colonization [30,31]. The gene discussed is CD44; the disease is cancer.